Desmopressin Melt

Phase 3Small molecule

Desmopressin Melt is one of 50 small molecule programs targeting Central diabetes insipidus. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Central Diabetes InsipidusActive, not recruiting

Renal ColicActive, not recruiting

PolyuriaActive, not recruiting

Central Diabetes InsipidusPhase 3

Active, not recruiting

Renal ColicPhase 3

Active, not recruiting

PolyuriaPhase 3

Active, not recruiting

Competition

Competitive Landscape

52 competitors in Renal Colic

#DrugCompanyPhaseTrials

MS Contin

HHikma Pharmaceuticals LLC

Approved

6 2

Oruvail

WWyeth-Lederle Vaccines

Approved

2 3

Naropin

FFresenius Kabi Oncology Ltd.

Approved

2 4

Duragesic

CCephalon

Approved

2 5

Suboxone

IIndivior Inc.

Approved

1 6

Celebrex

PPhiladelphia Eye Associates

Approved

1 7

Demerol

QQuagen

Approved

1 8

Keterol

PPamukkale University

Approved

1 9

Paracetamol

GSK

Approved

4 10

Ketalar

AAultman Health Foundation

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Efficacy and Safety1 trial

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Completed· Ferring logo

Ferring·Phase 3·NCT00615836·554 enrolled

Renal Colic1 trial

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

Unknown status·TTehran University of Medical Sciences·Phase 3·NCT01742689·88 enrolled

Polyuria1 trial

Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Completed· Ferring logo

Ferring·Phase 3·NCT03051009·503 enrolled

Central diabetes insipidus1 trial

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Completed· Ferring logo

Ferring·Phase 3·NCT01280188·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Desmopressin Melt. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Desmopressin Melt compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Desmopressin Melt. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ferring company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Ferring

Desmopressin Melt

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Efficacy and Safety1 trial

Renal Colic1 trial

Polyuria1 trial

Central diabetes insipidus1 trial

References

Drug Info

Quick Facts

Related News